CB43829-22B - 0x000000000000666F

Overweight Males & Females

Cardinal

* Stipend may pay up to reflected amount.
Start Date: 
April 8, 2025 - 3:00pm
End Date: 
May 28, 2025 - 9:30am

Study Details

Study Number: CB43829
Group Number: 22B
Study Requirement: Obese
Stipend: up to $9,000.00

Study Criteria

Age: 19 - 55
BMI: 27 - 39.9
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat obesity.
Route of Administration: Injection subcutaneous
Blood Draws: 21

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 3 Night Stay, Two - 2 Night Stays, One - 5 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Thursday 3/27/2025
Tuesday 4/1/2025
Wednesday 4/2/2025
Friday 4/4/2025
Monday 4/7/2025

Doctor Exam Dates:

Event Day Event Date
Thursday 3/27/2025
Tuesday 4/1/2025
Wednesday 4/2/2025
Friday 4/4/2025
Monday 4/7/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 4/8/2025 3:00:00 PM Friday 4/11/2025 10:00:00 AM 1 Lincoln
Check-In Wednesday 4/16/2025 6:00:00 AM Friday 4/18/2025 10:00:00 PM 1 Lincoln
Check-In Wednesday 4/23/2025 6:00:00 AM Friday 4/25/2025 10:00:00 PM 1 Lincoln
Check-In Wednesday 4/30/2025 6:00:00 AM Monday 5/5/2025 10:00:00 AM 1 Lincoln
Return Wednesday 5/7/2025 7:30:00 AM Wednesday 5/7/2025 9:30:00 AM 1 Lincoln
Return Saturday 5/10/2025 8:30:00 AM Saturday 5/10/2025 9:30:00 AM 1 Lincoln
Return Wednesday 5/14/2025 8:30:00 AM Wednesday 5/14/2025 9:30:00 AM 1 Lincoln
Return Wednesday 5/21/2025 8:30:00 AM Wednesday 5/21/2025 9:30:00 AM 1 Lincoln
Return Wednesday 5/28/2025 7:30:00 AM Wednesday 5/28/2025 9:30:00 AM 1 Lincoln